| 12/02/2008 | European Commission’s Pharmaceutical Sector Inquiry Report Finds Certain Practices May Delay Entry of Generic Medicines
|
| 10/16/2008 | The Federal Circuit Cipro Decision: Another Blow to the FTC's Fight Against Reverse Payment Settlements
|
| 09/30/2008 | Schwarzenegger Signs Green Chemistry Bills
Published with permission of Portfolio Media, Inc. © 2008. Originally published in Product Liability Law360. |
| 09/15/2008 | Federal Circuit Gives Big Nod to the Patent Office
|
| 07/18/2008 | Cigarette Cartel, Pharma Pricing- Recent UK Antitrust Rulings
|
| 06/10/2008 | Supreme Court Issues Ruling on Patent Exhaustion in Quanta v. LG Electronics
|
| 04/11/2008 | Morrison & Foerster Advises on Collaboration to Develop Water Efficient Maize for Africa ("WEMA")
|
| 03/12/2008 | Morrison & Foerster Advises BHK on AIM Listing
First Korean Company to list on AIM and the first Pharma/Life Science Issue of 2008 |
| 02/15/2008 | FTC Takes 4-in-1 Shot at Reverse Payment Settlements
|
| 01/17/2008 | European Commission Raids Pharmaceutical Companies to Start Sector Inquiry
|
| 12/03/2007 | Dolly Not Yet Turned To Lolly
|
| 11/14/2007 | Morrison & Foerster Advises Oxford Immunotec on $40 million Financing Round
Deal is largest financing round for 2 years for a European diagnostics company |
| 11/14/2007 | Morrison & Foerster Advises Maelor plc on Exclusive Licensing Agreement with Helsinn Healthcare SA
|
| 11/13/2007 | Biotechs: Show Me the Money
|
| 11/01/2007 | USPTO Enjoined from Enforcing New Rules
|
| 08/08/2007 | Morrison & Foerster Advises ReNeuron Group plc on U.S. Stem Cell Acquisition
|
| 07/27/2007 | Patent Reform Act of 2007
|
| 07/16/2007 | Morrison & Foerster Advises GW Pharmaceutical on Global Cannabinoid Research Collaboration
|
| 07/13/2007 | Biotechs: Recent VC Exit Trends
|
| 07/13/2007 | Morrison & Foerster Advises Intercell on Worldwide Vaccines Deal
|
| 06/18/2007 | Morrison & Foerster Represents Shanghai Century in US$168 Million Cross-Border Business Combination with Kelun Pharmaceutical
Transaction will be the first cross-border acquisition by an offshore listed company involving a share swap under China’s new M&A regulations |
| 04/30/2007 | Supreme Court Issues Groundbreaking Ruling Making It Easier to Invalidate Patents as Obvious
Longstanding Federal Circuit “Teaching-Suggestion-Motivation” test no longer the exclusive way to show obviousness |
| 04/05/2007 | Morrison & Foerster Advises on Pipeline Boosting Life Science Deals
Further deals this year reflect the industry trend |
| 02/20/2007 | Morrison & Foerster Advises Acambis Plc €30 Million Partnership Agreement with sanofi pasteur
|
| 02/20/2007 | Morrison & Foerster Advises GW on $273 Million Strategic Alliance with Otsuka
|
| 02/20/2007 | Morrison & Foerster Advises ReNeuron Group plc on £5.5 Million Placing
|
| 12/12/2006 | Venture Capital Investment in the Life Sciences Industry
|
| 10/06/2006 | Morrison & Foerster Advises on Three Life Sciences Fundraisings
|
| 06/01/2006 | World Competition Law and Economics Review: R&D Cooperation, Licensing and Marketing in the Biotechnology Field - EC Competition Law Aspects
|
| 04/28/2006 | Morrison & Foerster Represents Astellas Pharma in $815 Million European Deal for High-Profile Anemia Drugs
|
| 03/01/2006 | Morrison & Foerster Represents University of California in $200+ Million Settlement with Monsanto over Use of Dairy Cow Growth Hormone
Case involves one of first biotech patents ever sought in 1980, now sold as POSILAC and given to 30% of American dairy cows; UC gains 15 cents per dosage, greatly adding to ultimate value of settlement |
| 02/27/2006 | The Supreme Court to Decide Whether Licensees in Good Standing Are Permitted to Challenge Licensed Patents
|
| 01/20/2006 | Morrison & Foerster Represents Applied Biosystems Group in Acquisition of Ambion, Inc.
|
| 12/21/2005 | Morrison & Foerster Represents Avigen in AAV Gene Therapy Deal with Genzyme
|
| 12/14/2005 | Morrison & Foerster Advises Oxford BioMedica on £30.1 Million Placing and Open Offer
|
| 10/26/2005 | Morrison & Foerster Represented OXIS International, Inc. in its Proposed Acquisition of BioCheck, Inc.
|
| 10/14/2005 | MoFo SF Represents CoTherix in Follow On Offering
|
| 10/11/2005 | Morrison & Foerster Represents Dynavax Technologies Corporation in Follow-On Offering
|
| 09/27/2005 | Morrison & Foerster Closes Major China Pharmaceutical M&A Transaction
|
| 06/02/2005 | SmithKline: How the Expanding Inherent Anticipation Doctrine Affects Chemical Patents
Court of Appeals for the Federal Circuit, Decided: April 8, 2005 |
| 04/05/2005 | MoFo Assists Kirin with Nuvelo Collaboration
|
| 12/06/2004 | Morrison & Foerster Represented Pequot Ventures as Lead Investor in a $37 Million B-series Round in Prestwick Pharmaceuticals
|
| 12/01/2004 | MoFo Represents Thomas Weisel in $31M Round in QuatRx
|
| 11/17/2004 | Disclose Government-Funded Inventions or Else!
|
| 11/16/2004 | Morrison & Foerster Establishes Venture Intellectual Property Group
|
| 10/06/2004 | A New Era - AIM's Change of Status to an Exchange Regulated Market
|
| 09/17/2004 | Knorr-Bremse: The Federal Circuit Overrules Its Precedent And Reshapes Willfulness
|
| 07/21/2004 | Morrison & Foerster Advises Vernalis on Licence Agreement in Deal Worth $400 million
|
| 07/19/2004 | MoFo Adds Corporate Partner Scott Stanton to its San Diego Office
|
| 07/16/2004 | NanoBioNexus and MoFo Join Forces to Promote Partnering and Investment Opportunities in Nanobiotechnology
|
| 05/18/2004 | Judgment of European Court of Justice in IMS Health v. NDC Health
|
| 03/30/2004 | Ten Disclosure Danger Areas for Life Sciences Companies
|
| 01/28/2004 | Burying the "Equity Stake" Theory of Patent Damages
|
| 01/22/2004 | Gregory P. Einhorn Joins Patent Group in San Diego
|
| 12/02/2003 | Congress Passes Anti-Spam Law, Preempts Much State Anti-Spam Legislation
|
| 11/24/2003 | MoFo San Diego Assists in Raising Over $200 Million in Life Sciences Venture Capital in First Three Quarters of 2003
|
| 06/10/2003 | Europe to Join Japan and the US -- a Bolar Exemption in Europe?
|
| 05/27/2003 | MoFo Assists in Three of the Year's Largest US Biotech Financings
|
| 05/01/2003 | John Campbell Joins Jonathan Dickstein as Co-chair of Life Sciences Group
|
| 04/15/2003 | April 14th "HIPAA Deadline" Was Not the End of the Road for Compliance
|
| 02/04/2003 | Federal Circuit Clarifies Written Description Requirements for Certain Biological Materials and Finds a Rebuttable Presumption of Enablement for Both Claimed and Unclaimed Disclosures in Prior Art Patents
|
| 10/20/2002 | New Procedures Under HIPAA for Disclosure of Protected Health Information in Judicial and Administrative Proceedings
|
| 10/04/2002 | Federal Circuit Articulates 'Material Effect' Test for Best Mode Requirement
|
| 08/15/2002 | Federal Circuit Restates Law of Written Description for Biotech Patents
|
| 08/01/2002 | Proposed Amendments to the Israeli Research and Development Law, 5744-1984
|
| 04/08/2002 | HHS Announces Changes to HIPAA Medical Privacy Rule
|
| 01/08/2002 | MoFo Handles Largest Life-Science IPO of 2001
|
| 12/01/1998 | New Legislation Effective January 1, 1999 Creates Cal-COBRA Obligation and Outlaws Discrimination Based on Genetic Characteristics
|
| 11/01/1998 | New Legislation Effective January 1, 1999 Creates Cal-COBRA Obligation and Outlaws Discrimination Based on Genetic Characteristics
Employment Law Commentary, November 1998, Vol. 10 No. 11 |
| 01/12/1998 | Lawsuit Heats Up Over Patent on Common Prenatal Test, American Medical News
|
